» Articles » PMID: 18249105

Endocytosis Mechanisms and the Cell Biology of Antigen Presentation

Overview
Publisher Elsevier
Date 2008 Feb 6
PMID 18249105
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence revealed that presentation of soluble antigens is governed by the endocytosis mechanisms that determine the intracellular routing of the endocytosed antigens. Soluble antigens intended for classical exogenous MHC-II-restricted presentation are internalized into lysosomes. Soluble antigens destined for crosspresentation are taken up by distinct endocytosis mechanisms and are conveyed into stable early endosomes. Particulate antigens enter phagosomes, in which both MHC-I-restricted and MHC-II-restricted presentation is initiated. In this review, we discuss the mechanistical differences in presentation of soluble and particulate antigen, the correlation of various endocytic receptors with antigen routing and presentation, the differential expression of these receptors in antigen-presenting cell subsets with respect to their ability to crosspresent, and implications on the molecular mechanisms controlling cross-presentation.

Citing Articles

Immunoregulatory Properties of Immune Cells that Associate with the Lens Capsule Surface during Acute and Resolution Phases of Experimental Autoimmune Uveitis.

Le P, Mattapallil M, Caspi R, Stepp M, Menko A Am J Pathol. 2024; 194(11):2194-2211.

PMID: 39159867 PMC: 11627221. DOI: 10.1016/j.ajpath.2024.07.021.


Tumor Immune Cell Targeting Chimeras (TICTACs) For Targeted Depletion of Macrophage-Associated Checkpoint Receptors.

Morimoto M, Till N, Bertozzi C bioRxiv. 2023; .

PMID: 38106036 PMC: 10723462. DOI: 10.1101/2023.12.06.570444.


DC-targeting lentivectors for cancer immunotherapy.

Gea-Mallorqui E, Rowland-Jones S Immunother Adv. 2023; 3(1):ltad023.

PMID: 38020311 PMC: 10656295. DOI: 10.1093/immadv/ltad023.


Endocytosis in cancer and cancer therapy.

Banushi B, Joseph S, Lum B, Lee J, Simpson F Nat Rev Cancer. 2023; 23(7):450-473.

PMID: 37217781 DOI: 10.1038/s41568-023-00574-6.


Do advanced glycation end products contribute to food allergy?.

Smith P, Venter C, OMahony L, Canani R, Lesslar O Front Allergy. 2023; 4:1148181.

PMID: 37081999 PMC: 10111965. DOI: 10.3389/falgy.2023.1148181.